Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AADAT | Q8N5Z0 | 6/20 | 0.42 |
| ▸ | GOT1 | P17174 | 1/20 | 0.42 |
| ▸ | KYAT1 | Q16773 | 1/20 | 0.42 |
| ▸ | KYAT3 | Q6YP21 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ADK | P55263 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29999046 | 1.00 | AADAT (0.42) | AADATGOT1KYAT1KYAT3KMT2A | |
| SCHEMBL28045866 | 0.79 | EGFR (0.41) | KMT2AALDH1A1L3MBTL1P2RX4TSHR | |
| 2-Methyl-D-Diboa SCHEMBL13135829 | 0.79 | ALDH1A1 (0.54) | AADATKMT2AALDH1A1L3MBTL1NPC1 | |
| SCHEMBL30105900 | 0.79 | RECQL (0.36) | AADAT | |
| SCHEMBL13812449 | 0.78 | AADAT (0.47) | AADATALDH1A1TSHR | |
| SCHEMBL912624 | 0.74 | KYAT1 (0.47) | AADATKYAT1KYAT3KMT2AALDH1A1 | |
| SCHEMBL22631177 | 0.69 | AADAT (0.58) | AADATGOT1KYAT1KYAT3KMT2A | |
| SCHEMBL27841958 | 0.66 | KMT2A (0.34) | KMT2AALDH1A1L3MBTL1SIRT1P2RX4 | |
| SCHEMBL29987450 | 0.65 | MAOA (0.40) | KMT2AALDH1A1P2RX4 | |
| SCHEMBL69727 | 0.65 | RET (0.53) | KMT2AALDH1A1NPC1RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118782152-B | Organic heterocyclic biomarker for wild and cultivated four-large family fish population and application thereof | 中国水产科学研究院长江水产研究所 | 2025-05-20 | — | — | CN | claimed |
| CN-118782152-A | Organic heterocyclic biomarker for wild and cultivated four-large family fish population and application thereof | 中国水产科学研究院长江水产研究所 | 2024-10-15 | — | — | CN | claimed |
| EP-3447134-B1 | INCREASED FUNGAL RESISTANCE IN CROP PLANTS | KWS SAAT SE & CO KGAA (DE) | 2023-10-11 | — | — | EP | claimed |
| WO-2023180613-A1 | METHOD FOR PURIFYING BIOTECHNOLOGICALLY PRODUCED D-DIBOA | UNIVERSIDAD DE CÁDIZ (ES) | 2023-09-28 | — | — | WO | claimed |
| WO-2023082029-A1 | METHOD FOR PREPARING AN EXTRACT BASED ON ACANTHUS LEAVES (ACANTHUS MOLLIS) AS A NATURAL FUNGICIDE AND INSECTICIDE | BUZZETTI MORALES KARINA ANDREA (CL) | 2023-05-19 | — | — | WO | claimed |
| US-20210204574-A1 | Consumable Product Comprising Malted Wheat | Lantmannen Functional Foods AB (SE) | 2021-07-08 | — | — | US | claimed |
| CN-112770644-A | Consumable product comprising malted wheat | 兰特门内保健食品公司 | 2021-05-07 | — | — | CN | claimed |
| CN-118782152-B | Organic heterocyclic biomarker for wild and cultivated four-large family fish population and application thereof | 中国水产科学研究院长江水产研究所 | 2025-05-20 | — | — | CN | disclosed |
| CN-117105918-B | 1, 4-Benzoxazinone derivative with biological activity and preparation method and application thereof | 河南师范大学 | 2025-03-18 | — | — | CN | disclosed |
| WO-2025030164-A1 | METHOD FOR PROMOTING PLANT GROWTH AND MODULATING PLANT ARCHITECTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-06 | — | — | WO | disclosed |
| CN-118782152-A | Organic heterocyclic biomarker for wild and cultivated four-large family fish population and application thereof | 中国水产科学研究院长江水产研究所 | 2024-10-15 | — | — | CN | disclosed |
| CN-111247243-B | Increased fungal resistance in crop plants | 科沃施种子欧洲股份两合公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-117688479-A | Composite fault diagnosis method based on improved distributed butterfly optimization algorithm | 国网湖南省电力有限公司 | 2024-03-12 | — | — | CN | disclosed |
| US-20050255159-A1 | Porous calcium phosphate networks for synthetic bone material | UNIVERSITY OF MASSACHUSETTS | 2005-11-17 | — | — | US | disclosed |
| US-20050250772-A1 | Methods for inducing anti-anxiety and calming effects in animals and humans | SAVANNA HEALTH LLC | 2005-11-10 | — | — | US | disclosed |
| WO-2005102281-A2 | POROUS CALCIUM PHOSPHATE NETWORKS FOR SYNTHETIC BONE MATERIAL | UNIVERSITY OF MASSACHUSETTS (US) | 2005-11-03 | — | — | WO | disclosed |
| US-20040209877-A1 | Methods for augmenting immune defenses contemplating the administration of phenolic and indoleamine-like compounds for use in animals ans humans | SEROCTIN RESEARCH & TECHNOLOGY, INC. | 2004-10-21 | — | — | US | disclosed |
| US-20040192669-A1 | Novel compounds for use in weight loss and appetite suppression in humans | SEROCTIN RESEARCH & TECHNOLOGY, INC. | 2004-09-30 | — | — | US | disclosed |
| US-3882107-A | Zinc chelate of 2,4-dihydroxy-1,4(2H)-benzoxazine-3-one | UNIV IOWA STATE RES FOUND INC | 1975-05-06 | — | — | US | disclosed |
| US-3882107-A | Zinc chelate of 2,4-dihydroxy-1,4(2H)-benzoxazine-3-one | UNIV IOWA STATE RES FOUND INC | 1975-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192669-A1 | Novel compounds for use in weight loss and appetite suppression in humans | CPT1B, FABP4, EGLN1 | AADAT 205/4885GOT1 647/4885KYAT1 820/4885 |
| US-20040209877-A1 | Methods for augmenting immune defenses contemplating the administration of phenolic and indoleamine-like compounds for use in animals ans humans | HAAO, HMOX1, IDO1 | AADAT 26/4885GOT1 1247/4885KYAT1 1150/4885 |
| US-20050250772-A1 | Methods for inducing anti-anxiety and calming effects in animals and humans | CALM1, HAAO, MYB | AADAT 214/4885GOT1 1573/4885KYAT1 1720/4885 |
| US-20210204574-A1 | Consumable Product Comprising Malted Wheat | FABP6, MLN, FABP2 | AADAT 1317/4885GOT1 1170/4885KYAT1 2177/4885 |
| US-20050255159-A1 | Porous calcium phosphate networks for synthetic bone material | BMP2, SOST, BMP6 | AADAT 4798/4885GOT1 4325/4885KYAT1 4804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.